According to filings with the U.S. Securities and Exchange Commission, Kortuc USA is raising $108,661,959.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kazuyuki Matsuda played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Kortuc USA
Increasing the power of cancer radiotherapy. an innovative solution to eliminate hypoxia, the most fundamental issue in cancer. The core technology of KORTUC which stands for “Kochi Oxydol Radiation Therapy for Unresectable Carcinomas” was invented by Dr. Yasuhiro Ogawa, a professor emeritus at Kochi University in Japan. He as radiation oncologist with over 30 years of experience had been searching for a way to cure patients who suffer from non-operatable tumors and who wants to avoid surgical resections. With very limited financial resources, he has been studying to find the solution for the limits of radiotherapy on his own. Through thousands of cancer cases he treated as a practitioner, he accidentally discovered the hydrogen peroxide (H2O2) is the ultimate and very simple way to eliminate hypoxia in tumors. KORTUC Inc. was established in 2015 to conduct clinical studies and commercialize Dr. Ogawa’s discovery as the drug.

To learn more about Kortuc USA, visit http://kortuc.com/

Contact:
Kazuyuki Matsuda, Chief Executive Officer
650-384-5969

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.